An uncommon case of chronic myeloid leukemia with variant cytogenetic

An uncommon case of chronic myeloid leukemia with variant cytogenetic

Authors

  • Mohamed A Abdullah Department of Medical Oncology, Hematology Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
  • Aliaa Amer Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar
  • Zafar Nawaz Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar
  • Ali S Abdullah Department of Medical Education, Internal Medicine Section, Hamad Medical Corporation, Doha, Qatar
  • Ahmad Al-Sabbagh Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
  • Samah Kohla Clinical Pathology Department, Faculty of Medicine, AlAzhar University, Cairo, Egypt
  • Abdulqadir J Nashwan Department of Medical Oncology, Hematology Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
  • Mohamed A Yassin Department of Medical Oncology, Hematology Section, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Keywords:

CML, variant cytogenetic, accelerated phase

Abstract

Chronic Myeloid Leukemia (CML) is myeloproliferative neoplasm characterized by Philadelphia chromosome which is a balanced translocation between chromosome 9 and 22 in 90% of cases. However, variant cytogenetic still happens in 5-10 % of cases, the importance of which is controversial as well as its response to therapy, prognosis and progression to acute leukemias. Here we report a male patient with CML and variant cytogenetic who responded to low dose of Dasatinib (50 mg daily).

Downloads

Published

03-04-2018

How to Cite

1.
An uncommon case of chronic myeloid leukemia with variant cytogenetic. Acta Biomed [Internet]. 2018 Apr. 3 [cited 2024 Mar. 29];89(3-S):28-32. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/7217